Daktari Brings In $1.8M

Xconomy Boston — 

Daktari Diagnostics, a Cambridge, MA-based developer of an HIV diagnostics system for use in developing countries, has wrapped up $1.8 million in equity-based funding from 32 unnamed investors, according to an SEC filing. The firm has previously raised about $3.7 million, from a number individual investors, Hub Angels, Launchpad Venture Group, Mass Medical Angels, Norwich Ventures, Partners Innovation Fund, and has also attracted money from The Bill & Melinda Gates Foundation. Daktari is working on a device for testing blood in locations that lack traditional lab settings, and has serial biotech entrepreneur Stanley Lapidus and MIT Sloan School of Management professor Ed Roberts as members of its board of directors.